|
|
|
|
| LEADER |
05760nam a2200793 4500 |
| 001 |
ocn857664391 |
| 003 |
OCoLC |
| 005 |
20170124071346.6 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
130903s2014 nju ob 001 0 eng |
| 010 |
|
|
|a 2013035811
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d YDX
|d EBLCP
|d N$T
|d IDEBK
|d DG1
|d YDXCP
|d E7B
|d CUI
|d CUS
|d CDX
|d COO
|d RECBK
|d OCLCF
|d STF
|d OCLCQ
|d DEBBG
|d LOA
|d GrThAP
|
| 019 |
|
|
|a 905856541
|a 929527164
|a 960199933
|a 961650872
|a 962632779
|
| 020 |
|
|
|a 9781118778128 (ePub)
|
| 020 |
|
|
|a 111877812X (ePub)
|
| 020 |
|
|
|a 9781118778159 (Adobe PDF)
|
| 020 |
|
|
|a 1118778154 (Adobe PDF)
|
| 020 |
|
|
|z 9780470917374 (cloth)
|
| 020 |
|
|
|a 9781118778166
|
| 020 |
|
|
|a 1118778162
|
| 020 |
|
|
|a 0470917377
|
| 020 |
|
|
|a 9780470917374
|
| 020 |
|
|
|a 9781306571784
|
| 020 |
|
|
|a 1306571782
|
| 029 |
1 |
|
|a CHVBK
|b 325941823
|
| 029 |
1 |
|
|a CHBIS
|b 010259524
|
| 029 |
1 |
|
|a NZ1
|b 15922666
|
| 029 |
1 |
|
|a NZ1
|b 16097921
|
| 029 |
1 |
|
|a DEBBG
|b BV042792988
|
| 029 |
1 |
|
|a DEBBG
|b BV043396198
|
| 035 |
|
|
|a (OCoLC)857664391
|z (OCoLC)905856541
|z (OCoLC)929527164
|z (OCoLC)960199933
|z (OCoLC)961650872
|z (OCoLC)962632779
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM301.25
|
| 060 |
1 |
0 |
|a QV 745
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615.1/9
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Collaborative innovation in drug discovery :
|b strategies for public and private partnerships /
|c edited by Dr. Rathnam Chaguturu.
|
| 264 |
|
1 |
|a Hoboken, New Jersey :
|b John Wiley & Sons Inc.,
|c [2014]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 490 |
1 |
|
|a Wiley series on technologies for the pharmaceutical industry
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a Table of Contents; Wiley Series on Technologies for the Pharmaceutical Industry; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; General Principles for Success; Notes; 2: Divided We Fall; Challenges; Collaboration Models
|
| 505 |
8 |
|
|a Examples of Successful Biomedical CollaborationsPrinciples of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References; 4: The Changing Face of Innovation in Drug Discovery; Introduction; Core Objectives of the Drug Discovery Process
|
| 505 |
8 |
|
|a Major Innovations in Technology Have Advanced Drug DiscoveryAn Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery; Future Perspectives: Where Is Innovation Leading?; References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies
|
| 505 |
8 |
|
|a Probe Discovery in Public DomainEffective Management of Academia-Pharma Collaborations; Concluding Remarks; References; Notes; 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future Challenges; Evolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities
|
| 505 |
8 |
|
|a Funding for Collaborations with AcademiaNew Initiatives to Transform University-Industry Collaborations; Issues Affecting University-Industry Collaborations; Differences between Large- and Small-/Medium-Sized Companies; Large Companies Share Certain Characteristics; Small- and Medium-Sized Enterprises (SMEs) Offer a Contrasting Perspective; The National Academies' University-Industry Demonstration Partnership; Strategies for Building High-Value, High Return U-I Partnerships; Conclusion; Note on this Chapter; Note; References
|
| 650 |
|
2 |
|a Drug Discovery.
|
| 650 |
|
2 |
|a Public-Private Sector Partnerships.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a Public-private sector cooperation.
|2 fast
|0 (OCoLC)fst01083445
|
| 650 |
|
0 |
|a Drug Discovery.
|
| 650 |
|
0 |
|a Public-Private Sector Partnerships.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Public-private sector cooperation.
|
| 650 |
|
4 |
|a Public-Private Sector Partnerships.
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Chaguturu, Rathnam,
|e editor of compilation.
|
| 776 |
0 |
8 |
|i Print version:
|t Collaborative innovation in drug discovery
|d Hoboken, New Jersey : John Wiley & Sons Inc., [2014]
|z 9780470917374
|w (DLC) 2013035525
|
| 830 |
|
0 |
|a Wiley series on technologies for the pharmaceutical industry.
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118778166
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
